A new study has interrogated whether circulating plasma miRNAs can determine the risk of a small-for-gestational-age (SGA) birth. SGA foetuses are those who are in less than the 10th centile for weight at birth – this carries with it a high risk of stillbirth or long-term adverse outcomes. Stillbirth is one of the main causes […]
Embracing equality, diversity and inclusion (EDI) is not simply a matter of complying with the law, nor is it simply a matter of social justice. Diversity is essential to excellence in scientific endeavour. Our commitment to equality, diversity and inclusion recognises the fact that excellence comes through facilitating inclusive opportunities that bring together people with […]
A condition that causes loss of vertigo perception and imbalance has been diagnosed in traumatic brain injury patients for the first time. In a clinical study led by researchers at Imperial College London and clinicians at Imperial College Healthcare NHS Trust, out of 37 patients with acute traumatic brain injury (TBI), fifteen were diagnosed with a newly characterised neurological […]
Informatics ApproachesInnovationPartnership New understanding of genetic factors of Takayasu arteritis
Imperial researchers have derived a genetic risk score for Takayasu arteritis in a large scale genome-wide association study. Takayasu arteritis (TAK) is a form of vasculitis, which is a family of rare disorders categorised by inflammation of blood vessels, which can restrict blood flow and damage vital organs and tissues. While we know that the […]
DiagnosticInformatics ApproachesPrevention Blood plasma treatment has limited effect for sickest COVID-19 patients
Treating critically ill COVID-19 patients with blood plasma from people who have fought off the disease has limited impact on patient outcomes. The early findings, which are yet to be published, come from the REMAP-CAP study and show that treatment with convalescent plasma did not improve outcomes among patients requiring intensive care unit (ICU) support. […]
To accelerate our understanding and response to coronavirus, a COVID-19 specific de-identified dataset was created, pulling together data from Imperial College Healthcare NHS Trust and the region’s linked longitudinal dataset. Find out how to get access here.
NIHR Imperial BRC has established a new ‘virtual’ Theme, with the aim of acting as a focal and coordinating point for all the active and proposed research initiatives currently being directed towards the diagnosis and treatment of COVID-19 infection. Find out more about ongoing activities here.
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.